Advancing efficiency, control, traceability, and insight
A global life-sciences company (biotech/pharma) ran outdated, paper-based validation that caused inefficiency, high error rates, compliance risk, and scaling obstacles. It deployed Kneat's digital validation platform for its advanced features, intuitive interface, and enterprise-grade, life-sciences-specific architecture. Within five months of implementation, the company was managing thousands of protocols, had streamlined three validation processes, and saw significant gains in efficiency, traceability and compliance -- enough to plan a broader organizational rollout. The client's Project Leader said: 'Kneat has exceeded our expectations ... It's an excellent solution. We now have the efficiency, control, traceability, and insight we were missing.'
The customer is anonymised in Kneat’s own case study — not withheld by us.
Kneat is a paperless computer-system and process-validation platform — one of the two dominant players in digitizing the validation evidence GxP systems require before go-live.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Kneat on its own site — read the original case study on kneat.com ↗
Related use cases
- 01Merck Sharp & Dohme (MSD) reduced validation time by 50%
- 02Building a Leading-Edge Digital Validation Program From the Ground Up
- 03$500,000 Saved with Kneat eLogbooks
- 04Harmonization that works
- 05How Recipharm Advanced Bio transformed validation with Kneat Gx
- 06Douglas Pharma builds a data-driven future with Kneat Gx